Search

Your search keyword '"Loren, Alison"' showing total 952 results

Search Constraints

Start Over You searched for: Author "Loren, Alison" Remove constraint Author: "Loren, Alison"
952 results on '"Loren, Alison"'

Search Results

1. Cytokine-mediated CAR T therapy resistance in AML

2. Evolving racial/ethnic disparities in AML survival in the novel therapy era

7. Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors

9. Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

11. Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

12. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

13. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms

14. Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients

19. Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

21. Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation

25. Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial

28. Interim Results of a Phase I/II Trial of Intermediate-Dose Post-Transplantation Cyclophosphamide after Reduced Intensity Conditioned HLA-Mismatched Bone Marrow Transplantation for Older or Unfit Patients

29. Post-Transplant Frailty Phenotype Predicts Survival

30. One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.

32. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation

35. Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation

37. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants

42. One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant

43. Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia

44. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

45. Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay

46. Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.

Catalog

Books, media, physical & digital resources